Journal
EUROPEAN JOURNAL OF MEDICAL RESEARCH
Volume 21, Issue -, Pages -Publisher
BIOMED CENTRAL LTD
DOI: 10.1186/s40001-016-0201-5
Keywords
Hyaluronidase; Hyaluronic acid; Hyaluronan; Filler; Dermatosurgery; Aesthetic dermatology; Adjuvant; Spreading effect; Diffusion promotor
Categories
Funding
- Riemser Pharma
Ask authors/readers for more resources
Over the past 60 years, hyaluronidase has been successfully utilized in ophthalmic surgery and is now being implemented in dermatosurgery as well as in other surgical disciplines. The enzyme is considered a spreading factor as it decomplexes hyaluronic acid (also called hyaluronan, HA), an essential component of the extracellular matrix (ECM). When applied as an adjuvant, hyaluronidase enhances the diffusion capacity and bioavailability of injected drugs. Therefore, the enzyme has been used as a local adjuvant to increase the diffusion capacity of local anesthetics, increasing the analgesic efficacy, and the anesthetized area particularly in the first minutes following injection, resulting in diminished intra- and postoperative pain. In aesthetic medicine, the off-label use of hyaluronidase is considered the gold standard for the management of HA-filler-associated complications. Here, we review the clinical use, underlying biological mechanisms, and future directions for the application of hyaluronidase in surgical and aesthetic medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available